Acelity L.P. Inc. Appoints Two New Members to Its Board of Directors
27 May 2015 - 6:22PM
Business Wire
Acelity L.P. Inc., a global wound care and regenerative medicine
company, today announced the addition of Kevin J. Buehler and
Alexandre Décary to its Board of Directors, effective May 20, 2015.
Kevin and Alexandre bring tremendous business acumen and unique
expertise that will strengthen Acelity’s presence on a global
scale.
“Kevin and Alexandre bring strong experiences in both global
business and finance that will add unique and valuable perspectives
to Acelity’s Board,” said Joe Woody, President and CEO of Acelity.
“Kevin brings extensive management experience in the healthcare
industry and Alexandre has a tremendous financial and corporate
leadership background; collectively, their counsel will help to
guide Acelity’s growth as a global leader in wound care and
regenerative medicine.”
Kevin has more than 30 years of experience in the healthcare and
consumer industries, with knowledge of U.S. and international
operations. He has a distinguished career, most recently serving as
the Division Head of Alcon Laboratories, Inc., a division of
Novartis from April 2011 to May 2014. Kevin has held a variety of
leadership positions within the Alcon Laboratories organization,
including: Senior Vice President of Global Markets, Chief Marketing
Officer, and President and CEO of Alcon, Inc. Kevin served on the
Board of Directors for Alcon prior to the merger with Novartis. He
holds a BA from Carroll College in Waukesha, Wis., with
concentrations in business administration and political science. He
is a graduate of the Harvard Program for Management
Development.
Alexandre brings strong business, financial and accounting
experience to Acelity. Currently, Alexandre serves as senior
director, private equity, at PSP Investments, where he is
responsible for leading direct investments in various sectors.
Prior to joining PSP Investments in 2015, he was Vice President,
mergers and acquisitions, at Aimia Inc., a data-driven marketing
and loyalty analytics company where he was responsible for the
company's growth through strategic investments and acquisitions in
the G20. From 2004 to 2012, Alexandre worked at RBC Capital Markets
in the investment banking group where he had coverage
responsibility for Canadian companies across various sectors. He
began his career at Ernst & Young LLP in the audit and
corporate finance departments. Alexandre completed a bachelor’s
degree in Business Administration and a Graduate Diploma in Public
Accountancy degree from HEC Montréal, as well as a Masters in
Finance degree from the London Business School. He holds the CPA
(Canada) and CFA designations.
About Acelity
Acelity is a global wound care and regenerative medicine company
created by uniting the strengths of three companies, Kinetic
Concepts, Inc., LifeCell Corporation and Systagenix Wound
Management, Limited. We are committed to advancing the science of
healing and restoring people’s lives. Available in more than 75
countries, the innovative and complementary Acelity product
portfolio delivers value through solutions that speed healing and
lead the industry in quality, safety and customer experience.
Headquartered in San Antonio, Texas, Acelity employs more than
5,500 people around the world. We believe in enabling better
futures for everyone. Please visit acelity.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150527006346/en/
AcelityCorporate CommunicationsCheston Turbyfill,
+1-210-515-7757cheston.turbyfill@acelity.comorInvestor
RelationsCaleb Moore, +1-210-255-6433caleb.moore@acelity.com